FAS and type 2 diabetes mellitus: Subset analysis of patients with T2D demonstrated no difference in serum cFAS content (1.60 ± 0.77 vs. 1.43 ± 0.81, P = 0.6) and plaque FAS content (12.4 ± 4.1 vs. 15.7 ± 4.6, P = 0.17) between patients with DCSI score < 5 and ≥ 5 (Supplementary Fig. 2).